Biotech news
Americas
Two rivals withdrew from acquisition process| Agreement provides access to blockbuster medicines | Janssen Global Services | Sanofi. 13 December 2022
Biotech
What does it mean for women to be at the heart of our business? Janine Swarbrick and Sofie McPherson of HGF examine the gender balance in IP and what is being done to improve it. 15 November 2022
Biotech
Developments in microbiome tech are aimed at reducing the need for antibiotics in livestock farming and have led to some notable patenting trends and requirements, explains Rosie McDowell of EIP. 27 October 2022
Biotech
Arbitration panel awarded the sum to Acorda to cover past royalties and interest | Acorda can now source the multiple sclerosis drug elsewhere. 18 October 2022
Americas
Dispute against LabCorp claims wilful infringement | Plaintiff has also sued Illumina, Roche and Myriad in separate cases. 6 October 2022
Biotech
New partner specialises in chemical-related tech | USPTO-registered litigator is also certified licensing professional | Appointment follows several hires in firm’s patents department. 29 September 2022
Biotech
The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech. 27 September 2022
Biotech
Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out. 22 September 2022
Biotech
Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines. 15 September 2022
Biotech
Protecting new and inventive innovations in this increasingly crowded area is essential, explains Ine Vanderleyden of Mewburn Ellis. 23 August 2022